Cargando…

Psychoactive medication use and risk of suicide in long‐term care facility residents

OBJECTIVES: To investigate psychoactive medication use and risk of suicide in long‐term care facility (LTCF) residents aged 75 and above. A second aim was to investigate the role of psychiatric and medical conditions in the occurrence of suicide in LTCF residents. METHODS: A Swedish national registe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hedna, Khedidja, Fastbom, Johan, Jonson, Mattias, Wilhelmson, Katarina, Waern, Margda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306521/
https://www.ncbi.nlm.nih.gov/pubmed/35142388
http://dx.doi.org/10.1002/gps.5684
_version_ 1784752556806766592
author Hedna, Khedidja
Fastbom, Johan
Jonson, Mattias
Wilhelmson, Katarina
Waern, Margda
author_facet Hedna, Khedidja
Fastbom, Johan
Jonson, Mattias
Wilhelmson, Katarina
Waern, Margda
author_sort Hedna, Khedidja
collection PubMed
description OBJECTIVES: To investigate psychoactive medication use and risk of suicide in long‐term care facility (LTCF) residents aged 75 and above. A second aim was to investigate the role of psychiatric and medical conditions in the occurrence of suicide in LTCF residents. METHODS: A Swedish national register‐based cohort study of LTFC residents aged ≥75 years between 1 January 2008 and 31 December 2015, and followed until 31 December 2016 (N = 288,305). Fine and Gray regression models were used to analyse associations with suicide. RESULTS: The study identified 110 suicides (15.8 per 100,000 person‐years). Half of these occurred during the first year of residence. Overall, 54% of those who died by suicide were on hypnotics and 45% were on antidepressants. Adjusted sub‐hazard ratio (aSHR) for suicide was decreased in those who were on antidepressants (aSHR 0.64, 95% confidence interval 0.42–0.97), even after the exclusion of residents who had healthcare contacts for dementia or were on anti‐dementia drugs. The aSHR for suicide was more than two‐fold higher in those who were on hypnotics (2.20, 1.46–3.31). Suicide risk was particularly elevated in those with an episode of self‐harm prior to LTCF admittance (15.78, 10.01–24.87). Specialized care for depression was associated with increased risk, while medical morbidity was not. CONCLUSIONS: A lower risk of suicide in LTCF residents was found in users of antidepressants, while elevated risk was observed in those on hypnotics. Our findings suggest that more can be done to prevent suicide in this setting.
format Online
Article
Text
id pubmed-9306521
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93065212022-07-28 Psychoactive medication use and risk of suicide in long‐term care facility residents Hedna, Khedidja Fastbom, Johan Jonson, Mattias Wilhelmson, Katarina Waern, Margda Int J Geriatr Psychiatry Research Article OBJECTIVES: To investigate psychoactive medication use and risk of suicide in long‐term care facility (LTCF) residents aged 75 and above. A second aim was to investigate the role of psychiatric and medical conditions in the occurrence of suicide in LTCF residents. METHODS: A Swedish national register‐based cohort study of LTFC residents aged ≥75 years between 1 January 2008 and 31 December 2015, and followed until 31 December 2016 (N = 288,305). Fine and Gray regression models were used to analyse associations with suicide. RESULTS: The study identified 110 suicides (15.8 per 100,000 person‐years). Half of these occurred during the first year of residence. Overall, 54% of those who died by suicide were on hypnotics and 45% were on antidepressants. Adjusted sub‐hazard ratio (aSHR) for suicide was decreased in those who were on antidepressants (aSHR 0.64, 95% confidence interval 0.42–0.97), even after the exclusion of residents who had healthcare contacts for dementia or were on anti‐dementia drugs. The aSHR for suicide was more than two‐fold higher in those who were on hypnotics (2.20, 1.46–3.31). Suicide risk was particularly elevated in those with an episode of self‐harm prior to LTCF admittance (15.78, 10.01–24.87). Specialized care for depression was associated with increased risk, while medical morbidity was not. CONCLUSIONS: A lower risk of suicide in LTCF residents was found in users of antidepressants, while elevated risk was observed in those on hypnotics. Our findings suggest that more can be done to prevent suicide in this setting. John Wiley and Sons Inc. 2022-02-10 2022-03 /pmc/articles/PMC9306521/ /pubmed/35142388 http://dx.doi.org/10.1002/gps.5684 Text en © 2022 The Authors. International Journal of Geriatric Psychiatry published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Article
Hedna, Khedidja
Fastbom, Johan
Jonson, Mattias
Wilhelmson, Katarina
Waern, Margda
Psychoactive medication use and risk of suicide in long‐term care facility residents
title Psychoactive medication use and risk of suicide in long‐term care facility residents
title_full Psychoactive medication use and risk of suicide in long‐term care facility residents
title_fullStr Psychoactive medication use and risk of suicide in long‐term care facility residents
title_full_unstemmed Psychoactive medication use and risk of suicide in long‐term care facility residents
title_short Psychoactive medication use and risk of suicide in long‐term care facility residents
title_sort psychoactive medication use and risk of suicide in long‐term care facility residents
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306521/
https://www.ncbi.nlm.nih.gov/pubmed/35142388
http://dx.doi.org/10.1002/gps.5684
work_keys_str_mv AT hednakhedidja psychoactivemedicationuseandriskofsuicideinlongtermcarefacilityresidents
AT fastbomjohan psychoactivemedicationuseandriskofsuicideinlongtermcarefacilityresidents
AT jonsonmattias psychoactivemedicationuseandriskofsuicideinlongtermcarefacilityresidents
AT wilhelmsonkatarina psychoactivemedicationuseandriskofsuicideinlongtermcarefacilityresidents
AT waernmargda psychoactivemedicationuseandriskofsuicideinlongtermcarefacilityresidents